Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SB-200646A 是一个对 5-HT2B/2C 的选择性超过 5-HT2A 的拮抗剂,5-HT2B,5-HT2C 和 5-HT2A 的 pKi 值分别为 7.5、6.9 和 5.2。SB-200646A 具有口服活性,在体内具有电生理和抗焦虑特性。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 347 | 5日内发货 | ||
5 mg | ¥ 578 | 5日内发货 | ||
1 mL * 10 mM (in DMSO) | ¥ 638 | 5日内发货 |
产品描述 | SB-200646A is an orally active, selective antagonist of 5-HT2B/2C over 5-HT2A receptor with pKi of 7.5, 6.9 and 5.2 for 5-HT2B, 5-HT2C and 5-HT2A, respectively. SB-200646A exerts anxiolytic and electrophysiological properties in vivo. |
体外活性 | SB200646A (4 μM) abolishes the ethanol-induced increase in miniature inhibitory postsynaptic current (mIPSC) frequency and had no effect on basal mIPSC frequency. |
体内活性 | SB-200646A (20 mg/kg; intravenous injection; daily; for 21 days; male albino Sprague-Dawley rats) treatment significantly decreases the number of spontaneously active ventral tegmental area (VTA) dopaminergic neurons. The i.v. administration of 4-16 mg/kg of SB-200646A significantly increases the firing rate and % events as bursts in spontaneously active VTA dopaminergic neurons and significantly increases the % events as burst in substantia nigra pars compacta (SNC) dopaminergic neurons[1]. |
分子量 | 302.76 |
分子式 | C15H15ClN4O |
CAS No. | 143797-62-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 225 mg/mL (743.2 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.3029 mL | 16.5147 mL | 33.0295 mL | 82.5737 mL |
5 mM | 0.6606 mL | 3.3029 mL | 6.6059 mL | 16.5147 mL | |
10 mM | 0.3303 mL | 1.6515 mL | 3.3029 mL | 8.2574 mL | |
20 mM | 0.1651 mL | 0.8257 mL | 1.6515 mL | 4.1287 mL | |
50 mM | 0.0661 mL | 0.3303 mL | 0.6606 mL | 1.6515 mL | |
100 mM | 0.033 mL | 0.1651 mL | 0.3303 mL | 0.8257 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
SB-200646A 143797-62-0 GPCR/G Protein Neuroscience 5-HT Receptor SB 200646A SB200646A Inhibitor inhibitor inhibit